Applied Therapeutics Inc (NASDAQ: APLT) kicked off on Friday, up 121.35% from the previous trading day, before settling in for the closing price of $0.56. Over the past 52 weeks, APLT has traded in a range of $0.29-$10.62.
During the last 5-year period, the sales growth of Healthcare Sector giant was 26.57%. While this was happening, its average annual earnings per share was recorded 24.67%. With a float of $125.42 million, this company’s outstanding shares have now reached $141.94 million.
Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 12.91%, while institutional ownership is 61.16%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.48 earnings per share (EPS), lower than consensus estimate (set at -0.16) by -0.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.40% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Take a look at Applied Therapeutics Inc’s (APLT) current performance indicators. Last quarter, stock had a quick ratio of 1.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1488.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Looking closely at Applied Therapeutics Inc (NASDAQ: APLT), its last 5-days average volume was 24.41 million, which is a jump from its year-to-date volume of 3.01 million. As of the previous 9 days, the stock’s Stochastic %D was 84.13%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 92.16%, which indicates a significant increase from 91.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0885 in the past 14 days, which was higher than the 0.0459 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4854, while its 200-day Moving Average is $0.5229. However, in the short run, Applied Therapeutics Inc’s stock first resistance to watch stands at $1.5199. Second resistance stands at $1.7999. The third major resistance level sits at $2.2797. If the price goes on to break the first support level at $0.7601, it is likely to go to the next support level at $0.2803. Now, if the price goes above the second support level, the third support stands at $0.0003.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
The company with the Market Capitalisation of 178.58 million has total of 144,012K Shares Outstanding. Its annual sales at the moment are 460 K in contrast with the sum of -105,620 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -21,330 K.
